HRMY — Harmony Biosciences Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapContrarian

Annual balance sheet for Harmony Biosciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	229	234	323	353	467
Net Total Accounts Receivable
Net Total Receivables	22.2	34.8	54.7	74.1	83
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	263	284	400	451	579
Net Property, Plant And Equipment	0.938	0.82	2.88	2.71	3.38
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	427	433	674	811	999
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	135	53.8	78.9	164	175
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	330	247	271	344	340
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	97.2	187	403	467	659
Total Liabilities & Shareholders' Equity	427	433	674	811	999
Total Common Shares Outstanding